136 related articles for article (PubMed ID: 21552020)
21. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
Börner AR; Müller-Gärtner HW
Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
[TBL] [Abstract][Full Text] [Related]
22. Iodine-131 contamination from thyroid cancer patients.
Ibis E; Wilson CR; Collier BD; Akansel G; Isitman AT; Yoss RG
J Nucl Med; 1992 Dec; 33(12):2110-5. PubMed ID: 1460501
[TBL] [Abstract][Full Text] [Related]
23. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
24. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
Tuttle RM; Leboeuf R; Robbins RJ; Qualey R; Pentlow K; Larson SM; Chan CY
J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
[TBL] [Abstract][Full Text] [Related]
25. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
[TBL] [Abstract][Full Text] [Related]
26. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
27. Radioiodine and radiotherapy in the management of thyroid cancers.
Simpson WJ
Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
[TBL] [Abstract][Full Text] [Related]
28. Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient
Gomes-Lima CJ; Wu D; Kharazi PH; Khojekar GJ; Ringel MD; Vetter RJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2017 Dec; 27(12):1558-1565. PubMed ID: 29132255
[TBL] [Abstract][Full Text] [Related]
29. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
[No Abstract] [Full Text] [Related]
30. Radiation safety considerations for post-iodine-131 thyroid cancer therapy.
Culver CM; Dworkin HJ
J Nucl Med; 1992 Jul; 33(7):1402-5. PubMed ID: 1613585
[TBL] [Abstract][Full Text] [Related]
31. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
32. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
[TBL] [Abstract][Full Text] [Related]
33. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
Clarke SE
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
[No Abstract] [Full Text] [Related]
34. [Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].
Günter HH; Junker D; Schober O; Hundeshagen H
Strahlenther Onkol; 1987 Mar; 163(3):185-91. PubMed ID: 3563879
[TBL] [Abstract][Full Text] [Related]
35. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
Katz N; Esik O; Füzy M; Gundy S
Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
[TBL] [Abstract][Full Text] [Related]
36. Hand exposure of nuclear medicine workers during administration of radioiodine.
Wrzesien M; Olszewski J
Radiat Prot Dosimetry; 2012 Aug; 151(1):147-52. PubMed ID: 22147924
[TBL] [Abstract][Full Text] [Related]
37. Outpatient therapeutic nuclear oncology.
Turner JH
Ann Nucl Med; 2012 May; 26(4):289-97. PubMed ID: 22222779
[TBL] [Abstract][Full Text] [Related]
38. Radiation doses to patient's relatives following radioiodine therapy.
Sulaiman BT; Clarke SE
Med J Malaysia; 1996 Mar; 51(1):131-3. PubMed ID: 10967992
[TBL] [Abstract][Full Text] [Related]
39. Spatial dose mapping for individualizing radioiodine treatment.
Lassmann M; Hänscheid H
J Nucl Med; 2007 Jan; 48(1):2-4. PubMed ID: 17204691
[No Abstract] [Full Text] [Related]
40. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
Juweid ME; Hajjar G; Stein R; Sharkey RM; Herskovic T; Swayne LC; Suleiman S; Pereira M; Rubin AD; Goldenberg DM
J Nucl Med; 2000 Jan; 41(1):93-103. PubMed ID: 10647610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]